AviadoBio
Phase 1/2At AviadoBio, we are relentlessly chasing cures by developing and translating groundbreaking science and precision delivery into life-changing medicines across neurodegenerative diseases.
Founded
2021
Focus
RNA & Gene Therapy
About
At AviadoBio, we are relentlessly chasing cures by developing and translating groundbreaking science and precision delivery into life-changing medicines across neurodegenerative diseases.
Funding History
2Total raised: $145M
Series B$65MMonashee Investment ManagementJan 15, 2023
Series A$80MNew Enterprise AssociatesOct 15, 2021
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePhase 1/2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile